SHIMATSU, Akira et al. OSILODROSTAT IS EFFECTIVE AND WELL- TOLERATED IN ASIAN AND NON-ASIAN PATIENTS WITH CUSHING’S DISEASE: RESULTS FROM LINC 3 (PHASE III STUDY). Journal of the ASEAN Federation of Endocrine Societies, [S. l.], v. 37, n. 2, p. 75–76, 2022. DOI: 10.15605/jafes.037.AFES.118. Disponível em: https://asean-endocrinejournal.org/index.php/JAFES/article/view/6075. Acesso em: 18 jun. 2026.